Chapman University
Genetic Mutations of K<sub>Ca</sub>2.3 and K<sub>Ca</sub>3.1 Channels Affect Ca2+ Sensitivity
Abstract
dc:description.abstract<p>The Ca<sup>2+</sup>-activated potassium channels K<sub>Ca</sub> channels are a unique family of potassium channels activated by intracellular calcium. K<sub>Ca </sub>channels are critical for maintaining K<sup>+</sup> homeostasis and modulate several physiological processes, from the firing properties of neurons to the control of the transmitter release. The Ca<sup>2+</sup> sensitivity of these channels allows intracellular Ca<sup>2+</sup> to regulate the electrical activity of the cell membrane. Increased Ca<sup>2+</sup> sensitivity of K<sub>Ca </sub>channels caused by gain of function mutations (GOF) in the <em>KCNN</em> genes results in a broad spectrum of human channelopathies, including Zimmermann- Laband syndrome (ZLS), idiopathic non-cirrhotic portal hypertension (INCPH), and hereditary xerocytosis (HX). The impact of dysfunctional K<sub>Ca</sub>2.3/K<sub>Ca</sub>3.1 channels on human health has not been well documented. In this dissertation, I used inside-out patch clamp recordings to measure the apparent Ca<sup>2+</sup> sensitivity of K<sub>Ca</sub>2.3 and K<sub>Ca</sub>3.1 heterologously expressed in HEK293 cells. Wild-type K<sub>Ca</sub>2.3 channels have a Ca<sup>2+</sup> EC<sub>50</sub> value of ∼0.3 μM, while the apparent Ca<sup>2+</sup> sensitivity of wild-type K<sub>Ca</sub>3.1 channels is ∼0.27 μM. The equivalent mutations related to the ZLS and INCPH in the S<sub>45</sub>A/S<sub>45</sub>B helices increased the apparent Ca<sup>2+</sup> sensitivity of both K<sub>Ca</sub>2.3 & K<sub>Ca</sub>3.1 channel subtypes. However, the equivalent mutations related to the HX in HA/HB helices of K<sub>Ca</sub>2.3 and K<sub>Ca</sub>3.1 affected their apparent Ca<sup>2+</sup> sensitivity differently. AP14145 reduced the apparent Ca<sup>2+ </sup>sensitivity of the hypersensitive mutant K<sub>Ca</sub>2.3 channels. The results of my Ph.D. project would suggest the potential therapeutic usefulness of negative gating modulators as a novel target in these channelopathy-causing mutations. At the same time would guide us to design more potent and subtype-selective positive modulators targeting these channels.</p>
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (PhD)
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Pharmaceutical Sciences
- Year
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Orfali, Razan
- Contributors dc:contributor
-
- Miao Zhang, Ph.D., Chair
- Kamaljit Kaur, Ph.D.
- Meng Cui, Ph.D.
- Sun Yang, Ph.D.
Subjects
dc:subject × 4Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.chapman.edu/pharmaceutical_sciences_dissertations/26
- OAI identifier oai:identifier
- oai:digitalcommons.chapman.edu:pharmaceutical_sciences_dissertations-1027